Abstract:Aim: To evaluate the characteristics and the hypoglycemic efficacy of insulin liposomes coated by chitosan-EDTA conjugates(CEC) having different degrees of modification and concentrations after oral administration in mice. Method: CEC was synthesized from chitosan. Insulin-liposomes were prepared by reversed-phase evaporation. CEC coating was carried out by mixing the liposomal suspensions with the CEC solution, followed by incubation. The morphological examination of insulin-liposomes was performed with transmission electron microscopy (TEM). The particle size and Zeta potential were analyzed by using photon correlation spectroscopy and laser doppler anemometry. The entrapment efficiency was determined with HPLC and ultracentrifuge. The protection of insulin from peptic and tryptic digestion was studied with HPLC. The hypoglycemic effects of CEC-coated insulin liposomes were investigated using the glucose oxidase method after oral administration in mice. Result: A molar ratio of 1:20(D-glucosamine subunit of chitosan: EDTA) leads to an almost quantitative modification of all free amino groups. A higher excess of EDTA during the coupling reaction did not lead to a higher degree of modification. In contrast, a lower molar ratio than 1:20 leads to a polymer conjugate of comparable higher viscosity. The Zeta potentials and the particle sizes of CEC-coated insulin-liposomes were found to be increased with increasing concentration of CEC, but slightly decreased with increasing degree of modification. The entrapment efficiencies had no obvious correlation with the degree of quaternization and the concentration of CEC. All insulin-liposomes were of spherical or ellipsoidal shape. In peptic solutions, CEC and CEC-coated liposomes had abilities of protecting insulin from peptic digestion, which were increased with increased concentration of CEC. However, the abilities of CEC-coated liposomes were slightly lower than those of CEC. In all CEC-coated liposomes, the protective action of CEC2-coated liposomes was the strongest. In tryptic solutions, CEC had the ability of protecting insulin from tryptic digestion. However, CEC-coated liposomes had no protective action of insulin, even it could enhance digestion of insulin. All CEC-coated liposomes had definite hypoglycemic effects, and the effect was found to be increased with increasing concentration of CEC. As compared with the other CEC-coated insulin liposomes, CEC2-coated insulin liposomes have better hypoglycemic effects. The minimum blood glucose was 39.3% of the initial blood glucose. The blood glucose reducing effect could last 4 h after oral administration by mice. Conclusion: Proteolytic activity of pepsin and trypsin could be inhibited by CEC. CEC-coated liposomes could enhance enteral absorption of insulin. Degree of modification and concentrations of CEC were well correlated with the hypoglycemic effect of CEC-coated insulin liposomes.

Hypoglycemic Efficacy of Chitosan-Coated Insulin Liposomes after Oral Administration in Mice.

[Hypoglycemic Effect of Polysaccharide-Coated Insulin Liposomes after Oral Administration in Mice].

Effects of Chitosan-EDTA Conjugates on Insulin Nano-liposomes

Studies on the Insulin-Liposomes Double-Coated by Chitosan and Chitosan-Edta Conjugates

Hypoglycemic Efficacy of TMC-coated Insulin Liposomes after Oral Administration in Mice

Study on hypoglycemic effect of oral insulin-loaded alginate/chitosan microspheres

Effect of Chitosan-Cysteine Conjugate on Enzymatic Degradation and Hypoglycemic Effect of Insulin

[Effects of the Liposomes Coated by Chitosan and Its Derivatives on the Gastrointestinal Transit of Insulin].

Optimization of the Formulation and Process for the Insulin Liposome Double-Coated with Chitosan and Chitosan EDTA Conjugates

Effect of Liposome Double-Coated with Chitosan and Chitosan-EDTA Conjugates on Oral Absorption of Insulin

Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.

Preparation and Pharmacodynamics of Low-Molecular-weight Chitosan Nanoparticles Containing Insulin

EFFECTS OF LMWS-CHITOSAN ON BLOOD GLUCOSE IN DIABETIC MICE

Optimization of the Extraction Process of Chitin from Shrimp Shell and Its Anti-diabetic Activity

Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system

Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media.

Effective Enhancement of Hypoglycemic Effect of Insulin by Liver-Targeted Nanoparticles Containing Cholic Acid-Modified Chitosan Derivative

Effects of Chitosan Oligosaccharide on Growth Performance, Serum Immune and Antioxidant Indexes of Mice

Physicochemical Characterization and in Vivo Hypolipidemic Effect of Chitosan-Coated Nuciferine Liposomes

Effects of Water-Soluble Low Molecular Chitosan on Plasma Glucose in Diabetic Rats

Effect of Chitosan, O-Carboxymethyl Chitosan, and N-[(2-Hydroxy-3-N,N-dimethylhexadecyl Ammonium)propyl] Chitosan Chloride on Overweight and Insulin Resistance in a Murine Diet-Induced Obesity